Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-01-16
Summary
This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.
Conditions
- Hematopoietic Stem Cell Transplantation
- Transplant Complication
- Cardiovascular Events
Sponsors & Collaborators
-
Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences)
collaborator UNKNOWN -
First Affiliated Hospital of Zhejiang University
collaborator OTHER -
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
collaborator OTHER -
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology
collaborator UNKNOWN -
Xinqiao hospital of the third military medical university
collaborator UNKNOWN -
The First Affiliated Hospital of Zhengzhou University
collaborator OTHER -
Sun Yat-sen University Cancer Center, Sun Yat-sen University
collaborator UNKNOWN -
Sichuan Provincial People's Hospital
collaborator OTHER -
First Affiliated Hospital of Harbin Medical University
collaborator OTHER -
First Affiliated Hospital Xi'an Jiaotong University
collaborator OTHER -
First Affiliated Hospital of Xinjiang Medical University
collaborator OTHER -
Chinese PLA General Hospital
collaborator OTHER -
Peking University Shenzhen Hospital
collaborator OTHER -
Peking University Third Hospital
collaborator OTHER -
Peking University First Hospital
collaborator OTHER -
Peking University People's Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-01
- Primary Completion
- 2036-06-30
- Completion
- 2036-12-31
Countries
- China
Study Locations
More Related Trials
-
Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
NCT06708130 ·Status: RECRUITING
-
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
NCT01879072 ·Status: COMPLETED
-
Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell Transplantation
NCT06484049 ·Status: NOT_YET_RECRUITING
-
Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients
NCT03659773 ·Status: COMPLETED ·Phase: NA
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT05945121 ·Status: RECRUITING ·Phase: NA
-
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
NCT07299123 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
NCT07028112 ·Status: RECRUITING
-
Cardiomyopathy Following Stem Cell Transplantation
NCT00352209 ·Status: COMPLETED
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life
NCT01930981 ·Status: COMPLETED
-
Intervention for Fatigue in HCT Recipients
NCT05715047 ·Status: RECRUITING ·Phase: NA
-
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867 ·Status: RECRUITING
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Pulmonary Follow-up After Stem Cell Graft
NCT03349372 ·Status: COMPLETED
-
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
NCT02338479 ·Status: UNKNOWN
-
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
NCT05768035 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
NCT02598752 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cord Blood Transplantation in Severe Aplastic Anemia
NCT01343953 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation
NCT02659657 ·Status: UNKNOWN ·Phase: PHASE2
-
Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant
NCT04118530 ·Status: COMPLETED
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING